Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.22 (market cap $2.27B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.01 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 20.4× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | VMRK | |
|---|---|---|
Market Cap | $2.27B | $46.41B |
Volume | 4,179,659 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $15.46 | $70.15 |
52-Week Low | $1.39 | $57.98 |
Enterprise Value | $2.14B | $55.52B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 4.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Vivmark Residential Common Shares of Beneficial Interest
Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →
